Clinical outcomes of patients with HER2-mutant advanced lung cancer: chemotherapies versus HER2-directed therapies

BACKGROUND: Lung cancer is now the leading cause of cancer mortality worldwide for both men and women. In non-small cell lung cancer (NSCLC), matching a specifically targeted drug to the identified driver mutation in each patient resulted in dramatically improved therapeutic efficacy, often in conju...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Med Oncol
Main Authors: Zhou, Jiebai, Ding, Ning, Xu, Xiaobo, Zhang, Yong, Ye, Maosong, Li, Chun, Hu, Jie
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325548/
https://ncbi.nlm.nih.gov/pubmed/32647540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920936090
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker